Ontology highlight
ABSTRACT: Background
The cyclin-dependent kinase (CDK) inhibitor p27(Kip)¹ is downregulated in a majority of human cancers due to ectopic proteolysis by the ubiquitin-proteasome pathway. The expression of p27 is subject to multiple mechanisms of control involving several transcription factors, kinase pathways and at least three different ubiquitin ligases (SCF(SKP)², KPC, Pirh2), which regulate p27 transcription, translation, protein stability and subcellular localization. Using a chemical genetics approach, we have asked whether this control network can be modulated by small molecules such that p27 protein expression is restored in cancer cells.Results
We developed a cell-based assay for measuring the levels of endogenous nuclear p27 in a high throughput screening format employing L
SUBMITTER: Rico-Bautista E
PROVIDER: S-EPMC3025922 | biostudies-literature | 2010 Dec
REPOSITORIES: biostudies-literature